VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,711,000 | -15.1% | 967,859 | 0.0% | 0.19% | +12.0% |
| Q3 2017 | $17,325,000 | +9.8% | 967,859 | 0.0% | 0.17% | +0.6% |
| Q2 2017 | $15,776,000 | +2144.1% | 967,859 | +1828.0% | 0.16% | +1962.5% |
| Q1 2017 | $703,000 | -94.1% | 50,200 | -93.3% | 0.01% | -94.7% |
| Q4 2016 | $11,963,000 | -4.1% | 750,000 | 0.0% | 0.15% | +7.0% |
| Q3 2016 | $12,480,000 | +69.5% | 750,000 | +64.8% | 0.14% | +65.1% |
| Q2 2014 | $7,362,000 | -2.0% | 455,000 | -1.6% | 0.09% | -6.5% |
| Q1 2014 | $7,514,000 | -38.8% | 462,400 | -53.3% | 0.09% | -49.2% |
| Q4 2013 | $12,286,000 | +705.1% | 990,000 | +610.2% | 0.18% | +570.4% |
| Q3 2013 | $1,526,000 | – | 139,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |